224 related articles for article (PubMed ID: 20127690)
1. Proteomics of drug resistance in Candida glabrata biofilms.
Seneviratne CJ; Wang Y; Jin L; Abiko Y; Samaranayake LP
Proteomics; 2010 Apr; 10(7):1444-54. PubMed ID: 20127690
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
3. Candida albicans biofilm formation is associated with increased anti-oxidative capacities.
Seneviratne CJ; Wang Y; Jin L; Abiko Y; Samaranayake LP
Proteomics; 2008 Jul; 8(14):2936-47. PubMed ID: 18655069
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of experimentally induced azole resistance in Candida glabrata.
Rogers PD; Vermitsky JP; Edlind TD; Hilliard GM
J Antimicrob Chemother; 2006 Aug; 58(2):434-8. PubMed ID: 16735426
[TBL] [Abstract][Full Text] [Related]
5. In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.
Kucharíková S; Neirinck B; Sharma N; Vleugels J; Lagrou K; Van Dijck P
J Antimicrob Chemother; 2015 Mar; 70(3):846-56. PubMed ID: 25406296
[TBL] [Abstract][Full Text] [Related]
6. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
7. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
[TBL] [Abstract][Full Text] [Related]
8. Expression of CgCDR1, CgCDR2, and CgERG11 in Candida glabrata biofilms formed by bloodstream isolates.
Song JW; Shin JH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
Med Mycol; 2009; 47(5):545-8. PubMed ID: 18651314
[TBL] [Abstract][Full Text] [Related]
9. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
10. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms.
Seneviratne CJ; Silva WJ; Jin LJ; Samaranayake YH; Samaranayake LP
Arch Oral Biol; 2009 Nov; 54(11):1052-60. PubMed ID: 19712926
[TBL] [Abstract][Full Text] [Related]
11. Respiratory deficiency enhances the sensitivity of the pathogenic fungus Candida to photodynamic treatment.
Chabrier-Roselló Y; Foster TH; Mitra S; Haidaris CG
Photochem Photobiol; 2008; 84(5):1141-8. PubMed ID: 18248505
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
[TBL] [Abstract][Full Text] [Related]
13. Growth, biofilm formation, antifungal susceptibility and oxidative stress resistance of Candida glabrata are affected by different glucose concentrations.
Ng TS; Desa MNM; Sandai D; Chong PP; Than LTL
Infect Genet Evol; 2016 Jun; 40():331-338. PubMed ID: 26358577
[TBL] [Abstract][Full Text] [Related]
14. Biofilm lifestyle of Candida: a mini review.
Seneviratne CJ; Jin L; Samaranayake LP
Oral Dis; 2008 Oct; 14(7):582-90. PubMed ID: 19076549
[TBL] [Abstract][Full Text] [Related]
15. Physiologically Relevant Alternative Carbon Sources Modulate Biofilm Formation, Cell Wall Architecture, and the Stress and Antifungal Resistance of
Chew SY; Ho KL; Cheah YK; Sandai D; Brown AJP; Than LTL
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261727
[TBL] [Abstract][Full Text] [Related]
16. The Effectiveness of Voriconazole in Therapy of Candida glabrata's Biofilms Oral Infections and Its Influence on the Matrix Composition and Gene Expression.
Rodrigues CF; Gonçalves B; Rodrigues ME; Silva S; Azeredo J; Henriques M
Mycopathologia; 2017 Aug; 182(7-8):653-664. PubMed ID: 28439794
[TBL] [Abstract][Full Text] [Related]
17. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; López-Ribot JL
Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
[TBL] [Abstract][Full Text] [Related]
18. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
19. New regulators of biofilm development in Candida glabrata.
Riera M; Mogensen E; d'Enfert C; Janbon G
Res Microbiol; 2012 May; 163(4):297-307. PubMed ID: 22426249
[TBL] [Abstract][Full Text] [Related]
20. Cell wall composition and biofilm formation of azoles-susceptible and -resistant Candida glabrata strains.
Vitali A; Vavala E; Marzano V; Leone C; Castagnola M; Iavarone F; Angiolella L
J Chemother; 2017 Jun; 29(3):164-172. PubMed ID: 27439026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
